Chengdu Olymvax Biopharmaceuticals Inc. (SHSE: 688319)
Health Care · Biotechnology · CN
CN¥30.05
+5.29% today · -8.0% 1Y
Chengdu Olymvax Biopharmaceuticals Inc. (SHSE: 688319) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.81B and employs 451 people.
Over the last twelve months the share price has lost 8.0%, trading between 20.41 and 44.90.
Tweenvest scores Chengdu Olymvax Biopharmaceuticals Inc. across four factors: quality 57/100, value 25/100, growth 73/100. Its strongest factor is growth.
688319 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.81B
- Revenue (TTM)
- $111.83M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.51
- 52-week high
- CN¥44.90
- 52-week low
- CN¥20.41
- Avg volume (3M)
- —
- Shares outstanding
- 405.71M
- Employees
- 451
- Next earnings
- —
About Chengdu Olymvax Biopharmaceuticals Inc.
Chengdu Olymvax Biopharmaceuticals Inc. specializes in the research, development, and distribution of vaccines. Their current product portfolio includes immunizations against tetanus, a severe and often fatal infectious disease that damages the nervous system due to toxins produced by Clostridium tetani, alongside a vaccine for Haemophilus influenzae type b. Beyond their existing offerings, the company is actively advancing new vaccine candidates targeting Staphylococcus aureus, a prevalent bacterium responsible for both hospital-acquired and community infections, and illnesses associated with Group A streptococcus. This enterprise was established in 2009 and operates from its base in Chengdu, China.
- ISIN
- CNE1000051H8
- Founded
- 2009
- Listed since
- Jun 8, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.80 | +0.00% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $444.99 | +0.62% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.10 | -0.45% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.50 | -0.06% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €903.40 | +2.75% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $154.84 | -2.51% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.